Here are what the editors at HealthDay consider to be the most important developments in Family Practice for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Pharmaceutical Executive Defends 400 Percent Price Hike
FRIDAY, Sept. 28, 2018 (HealthDay News) — A pharmaceutical executive is defending his company’s 400 percent price hike on an antibiotic, according to a report published in Formulary Watch.
Increased Cardiovascular Risk for Diclofenac Initiators
FRIDAY, Sept. 28, 2018 (HealthDay News) — Diclofenac initiators have increased cardiovascular risk compared with non-initiators, according to a study published online Sept. 4 in The BMJ.
Handheld Device Inspired by Star Trek May Allow Rapid Diagnosis
FRIDAY, Sept. 28, 2018 (HealthDay News) — A device inspired by the Star Trek famous tricorder device pairs a handheld sensor with a smartphone app to measure the levels of various metabolites associated with multiple diseases in fluid samples from patients, according to a report published in an upcoming issue of Biosensors and Bioelectronics.
Tenth-Graders Use Combustible, Edible, Vaporized Cannabis
FRIDAY, Sept. 28, 2018 (HealthDay News) — Among 10th-grade students using cannabis, edible and vaporized products are used in addition to combustible products, with 61.7 percent reporting multiple administration methods, according to a study published online Sept. 28 in JAMA Network Open.
Physicians Often Don’t Address Their Burnout
FRIDAY, Sept. 28, 2018 (HealthDay News) — More than half of physicians experience burnout, and many do not seek treatment for burnout, according to a report published in the American Medical Association’s AMA Wire.
Implementing EMRs Affects Time Spent With Patients in Clinic
FRIDAY, Sept. 28, 2018 (HealthDay News) — Following a six-month learning period to implement an electronic medical record (EMR) system, outpatient orthopedic clinics return to pre-implementation efficiency, but there may be other lasting effects on productivity, according to a study published in the Sept. 19 issue of The Journal of Bone & Joint Surgery.
Proton Pump Inhibitor Use Tied to Hip Fracture in Dialysis Patients
FRIDAY, Sept. 28, 2018 (HealthDay News) — Proton pump inhibitor (PPI) use is associated with increased risk of hip fracture among dialysis patients, according to a study published online Sept. 27 in the Clinical Journal of the American Society of Nephrology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
CDC: Congenital Syphilis More Than Doubled Since 2013
Napping Opportunity May Improve Clinical Performance of Anesthesia Residents
2021 to 2025 Saw Reduction in Burnout Indicators Among Pediatricians
Odds of Imaging Order Higher When Clinicians Self-Interpret
Considerable Global Disparities Found in Access to Dermatological Care
Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants
Freshwater Swimming Tied to Stomach Bugs, Skin Conditions
Extreme Heat Linked to 33 Clinically Reportable Diagnoses
Psoriasis Linked to Impairment of Some Sleep Domains